Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2002

Jul 2, 2002

29831_dirs_2002-07-02_9c5317fc-1214-4ce9-b3ee-b2a7aed96393.zip

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

3 1 har97.htm CHARLES L. HARDWICK FORM 3 - JULY 1, 2002 SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0104 Expires: December 31, 2001 Estimated average burden hours per response. . . . . 0.5

  1. Name and Address of Reporting Person * Hardwick, Charles L. (Last) (First) (Middle) Pfizer Inc. Att: Corporate Secretary 235 East 42nd Street (Street) New York, NY 10017 (City) (State) (Zip) 2. Date of Event Requiring Statement (Month/Day/Year) July 01, 2002 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) 4. Issuer Name and Ticker or Trading Symbol Pfizer Inc (PFE) 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer Other Officer/Other Description Senior Vice President 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) X Individual Filing Joint/Group Filing

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form : (D) Direct (I) Indirect (Instr. 5) 4. Nature of Beneficial Ownership (Instr. 5)
Common Stock 7,789 D
Common Stock 39,242 I By Rule 16b-3 Plan

Hardwick, Charles L. - July 2002

Form 3 (continued)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4) 2. Date Exercisable(DE) and Expiration Date(ED) (DE) | (ED) 3. Title and Amount of of Underlying Security (Instr. 4) 4. Conversion or Exercise Price 5. Ownership Form (D) Direct or (I) Indirect (Instr. 5)
Employee Stock Option (right to buy) (1) | 08/27/2007 Common Stock - 9,998 $18.35 D
Employee Stock Option (right to buy) (2) | 08/26/2008 Common Stock - 66,000 $35.21 D
Employee Stock Option (right to buy) (3) | 04/21/2009 Common Stock - 72,450 $42.07 D
Employee Stock Option (right to buy) (4) | 02/23/2010 Common Stock - 44,000 $32.94 D
Employee Stock Option (right to buy) (5) | 02/21/2011 Common Stock - 44,500 $45.34 D
Employee Stock Option (right to buy) (6) | 02/27/2012 Common Stock - 50,000 $41.30 D
Phantom Stock Units (SSP) Immed. | (7) Common Stock - 2,376 1-for-1 D

Explanation of Responses :

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. /s/ Lawrence A. Fox for Charles L. Hardwick July 1, 2002 ** Signature of Reporting Person Date Lawrence A. Fox for Charles L. Hardwick Page 2 SEC 1473 (3-99)

Hardwick, Charles L. - July 2002

Form 3 (continued)

FOOTNOTE Descriptions for Pfizer Inc (PFE) Form 3 - July 2002 Charles L. Hardwick Pfizer Inc. Att: Corporate Secretary 235 East 42nd Street New York, NY 10017 Explanation of responses: (1) The option became exercisable in 5 equal annual installments beginning on August 28,1998. (2) The option became exercisable in 5 equal annual installments beginning on August 28, 1999. (3) The option became exercisable in 5 equal annual installments beginning on April 23, 2000. (4) The option became exercisable in 5 equal annual installments beginning on February 24, 2001. (5) The option became exercisable in 5 equal annual installments beginning on February 25, 2002. (6) This option becomes exercisable in 5 equal annual installments beginning on February 28, 2003. (7) These units are settled in cash following the reporting person's separation from service.

Page 3